Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design.
Publication
, Journal Article
Hess, KR; Abbruzzese, JL
Published in: J Clin Oncol
August 1, 2001
Duke Scholars
Published In
J Clin Oncol
DOI
ISSN
0732-183X
Publication Date
August 1, 2001
Volume
19
Issue
15
Start / End Page
3445 / 3446
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Pancreatic Neoplasms
- Oncology & Carcinogenesis
- Matrix Metalloproteinase Inhibitors
- Hydroxamic Acids
- Humans
- Enzyme Inhibitors
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hess, K. R., & Abbruzzese, J. L. (2001). Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design. J Clin Oncol, 19(15), 3445–3446. https://doi.org/10.1200/JCO.2001.19.15.3445
Hess, K. R., and J. L. Abbruzzese. “Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design.” J Clin Oncol 19, no. 15 (August 1, 2001): 3445–46. https://doi.org/10.1200/JCO.2001.19.15.3445.
Hess KR, Abbruzzese JL. Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design. J Clin Oncol. 2001 Aug 1;19(15):3445–6.
Hess, K. R., and J. L. Abbruzzese. “Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design.” J Clin Oncol, vol. 19, no. 15, Aug. 2001, pp. 3445–46. Pubmed, doi:10.1200/JCO.2001.19.15.3445.
Hess KR, Abbruzzese JL. Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design. J Clin Oncol. 2001 Aug 1;19(15):3445–3446.
Published In
J Clin Oncol
DOI
ISSN
0732-183X
Publication Date
August 1, 2001
Volume
19
Issue
15
Start / End Page
3445 / 3446
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Pancreatic Neoplasms
- Oncology & Carcinogenesis
- Matrix Metalloproteinase Inhibitors
- Hydroxamic Acids
- Humans
- Enzyme Inhibitors
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences